Target intelligence / Profile preview

Heat shock factor binding protein 1 (HSBP1)

Target
HSBP1
Molecular classification
Coiled-coil protein, negative regulator of heat shock response
01

Overview

Heat shock factor binding protein 1 (HSBP1) is a small, highly conserved coiled-coil protein comprised of 76 amino acids that functions as a negative regulator of the cellular heat shock response. HSBP1 binds specifically to the trimeric, active form of heat shock factor 1 (HSF1)—a master transcription factor of the heat shock protein family—in the nucleus and represses HSF1's DNA-binding and transactivation activity, effectively downregulating the expression of heat shock proteins required for cellular protection and protein folding under stress. Structural studies show HSBP1 predominantly forms trimers, with a unique alpha-helical organization enabling its regulatory function[1][4][5]. Expression of HSBP1 is linked to tumor differentiation in nasopharyngeal carcinoma, with lower levels in poorly differentiated, therapy-resistant subtypes[2]. There is no evidence for clinically approved drugs targeting HSBP1, but its regulatory effect on stress responses may have implications in cancer biology, aging, and cell survival.

Other names
Heat shock factor-binding protein 1HSBP1HSF1BPNPC-A-13Nasopharyngeal carcinoma-associated antigen 13
02

Mechanism of action

Not applicable (no direct drugs), but mechanistically, HSBP1 negatively regulates HSF1 activity, reducing heat shock protein expression[4][5].

03

Biological functions

Negative regulation of heat shock responseprotein–protein interaction (with HSF1)transcription corepressor activityregulation of protein folding stress responses
04

Disease associations

Cancer, particularly nasopharyngeal carcinomastress responsepotential relevance in aging and cellular survival under stress
05

Safety considerations

No direct therapeutic applications or toxicity data availableoverexpression disrupts heat shock response and may impact cell viability under stress[4]
06

Biomarkers

Changes in HSBP1 expression serve as a biomarker of tumor differentiation in nasopharyngeal carcinoma and correlate with radiosensitivity[2]

Beyond the preview

Go deeper on Heat shock factor binding protein 1 (HSBP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heat shock factor binding protein 1 (HSBP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call